Correlation Between Viatris and CG Oncology,
Can any of the company-specific risk be diversified away by investing in both Viatris and CG Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and CG Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and CG Oncology, Common, you can compare the effects of market volatilities on Viatris and CG Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of CG Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and CG Oncology,.
Diversification Opportunities for Viatris and CG Oncology,
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viatris and CGON is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and CG Oncology, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CG Oncology, Common and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with CG Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CG Oncology, Common has no effect on the direction of Viatris i.e., Viatris and CG Oncology, go up and down completely randomly.
Pair Corralation between Viatris and CG Oncology,
Given the investment horizon of 90 days Viatris is expected to generate 0.95 times more return on investment than CG Oncology,. However, Viatris is 1.05 times less risky than CG Oncology,. It trades about 0.14 of its potential returns per unit of risk. CG Oncology, Common is currently generating about -0.02 per unit of risk. If you would invest 1,143 in Viatris on September 3, 2024 and sell it today you would earn a total of 166.00 from holding Viatris or generate 14.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viatris vs. CG Oncology, Common
Performance |
| Timeline |
| Viatris |
| CG Oncology, Common |
Viatris and CG Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viatris and CG Oncology,
The main advantage of trading using opposite Viatris and CG Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, CG Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CG Oncology, will offset losses from the drop in CG Oncology,'s long position.| Viatris vs. Catalent | Viatris vs. Bausch Health Companies | Viatris vs. Tilray Inc | Viatris vs. Takeda Pharmaceutical Co |
| CG Oncology, vs. Paysafe | CG Oncology, vs. Sapiens International | CG Oncology, vs. VirnetX Holding Corp | CG Oncology, vs. Entravision Communications |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |